Compositions and methods for cancer imaging and radiotherapy
US11712486B2 · kind B2 · utility
0Cited by
4References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 30, 2018 |
| Grant date | Aug 1, 2023 |
| Priority date | — |
| Expiry date | Jan 30, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/705
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a conjugated compound comprising a marker M pharmaceutically acceptable, and a peptide or pseudo-peptide P having at most 30 amino acid residues and able to bind the Low-Density Lipoprotein Receptor (LDLR) and to its use in a method of labelling and/or detecting and/or treating cancerous cells in a subject by administration of the conjugated compound to the subject an analysis of the presence and/or the amount of marker.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.